The stock rose as much as 12 per cent to Rs. 723.The state's drug controller had suspended the manufacture, sale or distribution of fixed dose combination of Dicyclomine Hydrochloride IP 10mg, Tramadol Hydrochloride IP 50mg and Acetamenophen IP 325mg, Wockhardt had said in a statement on April 23. Wockhardt had not attributed any reason for the suspension.
Wockhardt said the products contributed less than 3 per cent of the consolidated sales of the company in the financial year that ended on March 31.
Wockhardt today in a statement to the BSE said, "The State Drug Controller, Himachal Pradesh has now revoked the suspension and accordingly the company will continue to manufacture, sell and distribute the Fixed Dose Combination (FDC) of Dicyclomine Hydrochloride IP 10mg, Tramadol Hydrochloride IP 50mg & Acetamenophen IP 325mg."
The pharma major had been earlier hit by export bans from some of its plants. Wockhardt has been barred from exporting drugs from some of its plants in India to the United States, its largest market, and Britain, in the last one year due to manufacturing quality issue.